secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001285550-25-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro Q2 revenue record $9.2M (+17% YoY); secures up to $105M note financing
--------------------------------------------------------------------------------

- Record Q2 revenue $9.2M, up 17% YoY; neurosurgery segment revenue up 33% to $3.4M.
- Operating expenses $11.2M (+16% YoY); gross margin 60% vs 63% on higher inventory reserves.
- Entered $105M note financing with Oberland Capital; $30M funded at closing plus $3.5M stock purchase.
- Cash and equivalents $41.5M at June 30, compared to $20.1M at year-end 2024.
- Full-year 2025 revenue outlook reaffirmed at $36.0M-$41.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555025000010/0001285550-25-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555025000010/clpt-20250812.htm
  HTML page:      https://secwatch.observer/filing/0001285550-25-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer